TNF and cancer: CCRA patients with concomitant AID are the most suitable candidates for this approach, but diagnosing AID in cancer patients using traditional iron biomarkers is challenging (6), due, for example, to ferritin upregulation by tumor necrosis factor-alpha (TNF-a) and pro-inflammatory cytokines (50, 51).